Ardaman Shergill to Prognosis
This is a "connection" page, showing publications Ardaman Shergill has written about Prognosis.
Connection Strength
0.447
-
Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA). Ann Surg Oncol. 2026 Sep; 33(9):8546-8554.
Score: 0.133
-
Association of Activating GNAS Mutations and Outcomes with Chemotherapy in Metastatic Appendiceal Adenocarcinoma. Ann Surg Oncol. 2026 Apr; 33(4):3453-3461.
Score: 0.130
-
Consensus Molecular Subtypes Inform HIPEC Agent Selection in Colorectal Cancer Peritoneal Metastases. Ann Surg Oncol. 2026 Jul; 33(7):6140-6145.
Score: 0.032
-
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial. JAMA Oncol. 2026 02 01; 12(2):149-158.
Score: 0.032
-
Consensus Guideline for the Management of Colorectal Cancer with Peritoneal Metastases. Ann Surg Oncol. 2026 Jun; 33(6):5260-5282.
Score: 0.031
-
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement. Ann Surg Oncol. 2026 Jun; 33(6):5142-5175.
Score: 0.031
-
Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement. Ann Surg Oncol. 2026 Jun; 33(6):5176-5203.
Score: 0.031
-
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5):831-840.
Score: 0.026